US Patent Issued to Triana Biomedicines on March 3 for "Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,492, issued on March 3, was assigned to Triana Biomedicines Inc. (Lexington, Mass.).

"Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof" was invented by Daniel La (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of the structural Formula (I):and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with ALK."

The patent was filed on Oct. 14, 2025, under Application No. 19/357,447.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2...